Blood-Thinning Drug Xarelto Faces 18,000 lawsuits Posted April 27, 2017 The first court test of Bayer/J&J’s billion-dollar bonanza, blood-thinner, Xarelto, is coming up in New Orleans next week. The outcome will influence how the 18,000 lawsuits behind it will be handled. Read more.